Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Phase III Trial of Lenalidomide Versus Observation in Asymptomatic High-Risk Smoldering Multiple Myeloma
2012-000750-66Phase 3Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in smoldering multiple myeloma (SMM) and multiple myeloma (MM) comparing Lenalidomide arm with Observation arm (2 arms). Primary endpoint: Progression-free survival. Started Sep 2012; status: completed.
02
Drugs
lenalidomide
03
Conditions
smoldering multiple myeloma (SMM)multiple myeloma (MM)
Beyond the preview
Go deeper on 2012-000750-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000750-66.